PCN175 BUDGET IMPACT ANALYSIS OF THE INCORPORATION OF MIDOSTAURIN FOR FLT3-POSITIVE ACUTE MYELOID LEUKEMIA (AML) IN THE BRAZILIAN PRIVATE HEALTHCARE SYSTEM (BPHS).
Nov 1, 2019, 00:00 AM
10.1016/j.jval.2019.09.371
https://www.valueinhealthjournal.com/article/S1098-3015(19)32749-4/fulltext
Section Title :
Section Order :
10307
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(19)32749-4&doi=10.1016/j.jval.2019.09.371